GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000105) » Definitions » Total Equity

Yuhan (XKRX:000105) Total Equity : ₩2,088,669 Mil (As of Mar. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Yuhan Total Equity?

Yuhan's total equity for the quarter that ended in Mar. 2024 was ₩2,088,669 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Yuhan Total Equity Historical Data

The historical data trend for Yuhan's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan Total Equity Chart

Yuhan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,649,991.37 1,846,502.19 1,935,889.09 2,007,806.37 2,101,732.64

Yuhan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,995,580.82 1,983,902.26 2,032,085.75 2,101,732.64 2,088,668.68

Yuhan Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Yuhan's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=2814070.522-712337.878
=2,101,733

Yuhan's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=2801252.649-712583.971
=2,088,669

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yuhan Total Equity Related Terms

Thank you for viewing the detailed overview of Yuhan's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Yuhan (XKRX:000105) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000105) » Definitions » Total Equity
Comparable Companies
XKRX:128940 XKRX:068760 XKRX:009420 XKRX:000250 XKRX:237690 XKRX:195940 XKRX:069620 XKRX:185750 XKRX:006280 XKRX:086450 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
000100:Korea
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Website
http://www.yuhan.co.kr
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000105) Headlines

No Headlines